Evaluation of clinical value of combined tumor markers detection   in diagnosis of lung cancer

ZHANG Guangming  DENG Shouzhen  WANG Yun  XU Lianqin    HE Wanting  GAO Quan  LIN Xiangtong

doi:null

您当前的位置：

首页 >

文章列表页 >

Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer

更新时间：2021-03-12

- Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer
- NUCLEAR TECHNIQUES Issue 5, (2002)
- 作者机构：
  
  1. 复旦大学附属华山医院
  2. 复旦大学附属华山医院,上海,200040
- 作者简介：
- 基金信息：
- DOI：
  CLC： R734.2
- Published：01 May 2002
- 稿件说明：
移动端阅览
[1]张光明,邓守真,王赟,徐莲琴,何婉婷,高泉,林祥通.肿瘤标志物联合检测在肺癌诊断中的临床价值[J].核技术,2002(05):380-382.

ZHANG Guangming DENG Shouzhen WANG Yun XU Lianqin HE Wanting GAO Quan LIN Xiangtong. Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer[J]. Nuclear techniques, 2002, (5): 380-382.
[1]张光明,邓守真,王赟,徐莲琴,何婉婷,高泉,林祥通.肿瘤标志物联合检测在肺癌诊断中的临床价值[J].核技术,2002(05):380-382. DOI：

ZHANG Guangming DENG Shouzhen WANG Yun XU Lianqin HE Wanting GAO Quan LIN Xiangtong. Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer[J]. Nuclear techniques, 2002, (5): 380-382. DOI：

摘要

为探讨血清肿瘤标志物CY2 1 - 1、CEA、CA1 5 - 3、SCC单项检测及联合检测在肺癌诊断中的临床价值。对 87例经细胞学或组织病理学证实诊断为肺癌的住院患者入院时血清CY2 1 - 1、CEA、CA1 5 - 3及SCC检测结果进行了分析。结果表明

（1 ）CY2 1 - 1、CEA、CA1 5 - 3及SCC单项检测对肺癌诊断的敏感度分别为 :5 9.8%、3 9.1 %、4 4.8%和 1 8.4 %。（2 ）联合检测对肺癌诊断的敏感度 :Ⅰ组 :CY2 1 - 1 +CEA为 78.2 %

Ⅱ组 :CY2 1 - 1 +CEA +CA1 5 - 3为 88.5 %

Ⅲ组 :CY2 1 - 1 +CEA +CA1 5 - 3 +SCC其诊断敏感度与Ⅱ组相同

Abstract

To evaluate clinical value of single or combined tumor marker detection CY21-1

CEA

CA15-3 and SCC in the diagnosis of lung cancer. There was retrospective analysis of 87 lung cancer in-patients

all of them was confirmed by pathology. Result showed: (1) Sensitivity of CY21-1

CEA

CA15-3 and SCC by single detection in diagnosing lung cancer was 59.8%

39.1%

44.8%

18.4%

respectively. (2) Sensitivity of groupⅠ (CY21-1+CEA) was 78.2%; sensitivity of group Ⅱ (CY21-1+CEA+CA15-3)was 88.5%; sensitivity of group Ⅲ (CY21-1+CEA+CA15-3+SCC) was the same as group Ⅱ. In the diagnosis of lung cancer

the combined detection with CY21-1

CEA

CA15-3 was an ideal selective combination.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Preparation and biodistribution study of ¹³¹I-BEV-PTX-SPIONs

Rapid detection of ⁹⁰Sr in biological samples

Value of the dual phase 18F-FDG PET/CT with oral diuretic in the diagnosis of bladder cancer before therapy

SPECT/CT fusion imaging for differential diagnosis of bone solitary metastases in patients with lung cancer

¹⁸F-FDG PET/CT imaging and diagnosis method of small intestine primary malignant neoplasms

Related Author

DU Minghua

ZHANG Dongsheng

QI Ning

JIAO Qingsong

BO Ling

ZHANG Jie

JI Anping

JI Faquan

Related Institution

College of Clinical Medicine, Southeast University

Department of Nuclear Medicine, The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine

Shandong Nuclear Power Company Ltd.

Yantai Entry-Exit Inspection and Quarantine Bureau

PET Center, Nanfang Hospital, Southern Medical University

AI问答

Address：2019 Jialuo Road, Jiading, Shanghai, China Postal code：201800
Tel：021-39194977 Email：LHB@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：881003 Visits Today：530

⁰